comprehensive -WSS

comprehensive

author：leisure time 2025-09-29 22:48:59 - browse：25826

Hevolution's executive team includes, from left, Sophia Pathai, Haya Bint Khaled Bin Bandar Al Saud, Mehmood Khan, and Salman AlAsiry. Courtesy Hashem Al-Sh

The Hevolution Foundation, a Saudi investment firm focused on aging science, said Wednesday that it is launching an incubator that will bring together experts from the scientific community, pharma, and multiple biotech VCs.

The incubator, called the Breakthrough Innovation Alliance, will give up to $1 million apiece to 10 different research initiatives over the next three years, allowing scientists and entrepreneurs to run preclinical research to determine whether the ideas hold any promise. The projects will be evaluated by a committee made up of representatives from Hevolution, Novo Nordisk, 5AM Ventures, RA Capital, and drug company EvoTec. The best projects will become the basis of new startups, co-funded by Hevolution.

It’s all part of Hevolution’s plan to funnel up to $1 billion each year into academic research and biotech startups that are focused on aging-related diseases and and helping people live healthier lives longer, or what is sometimes referred to as “healthspan.” As part of that effort, the firm also announced at a conference in the Saudi capital of Riyadh this week that it will give around $80 million to a handful of research initiatives, including $21 million to establish a partnership with the Buck Institute for Research on Aging.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Analysis of telehealth claims data suggest service duplication

focus

WSS

Liquid biopsy for lung cancer is launched by Delfi

Bill would stop addiction treatment from triggering child abuse inquiry

Bristol 'take

Histogen: Failed biotech offers rare public look inside

FDA rejects Alnylam's heart disease treatment over insufficient data

Bristol 'take

hotspot

comprehensive

focus

As demand for Covid shots wanes, Moderna seeks its next success

What to expect at HLTH 2023, the health care industry conference

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Hepatitis C has a cure — but many Americans still lack access to it

Rise in cancer among younger people worries and puzzles doctors

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Phenylephrine and the overlooked value of the placebo effect

Malaria cases in Florida and Texas: Here’s what you need to know

Roche’s Alnylam deal shows drug firms interested in heart drugs

hotspot

FDA panel signals lack of confidence in Amgen cancer drug data

Histogen: Failed biotech offers rare public look inside

3 questions for the future of Biden's cancer moonshot

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

When women are denied an abortion, their children fare worse than peers

Chemotherapy drug shortage eases slightly but still widespread

knowledge

focus

focus

hotspot